Molecular Diagnostics, the IVD industry’ segment, refers to the tests measuring DNA and RNA, as well as various products of metabolism to discover mutations, specific genotypes or any biochemical alterations which may be linked to certain health states or disease conditions. This science owns its emergence to the advancements in biology that have deepened the knowledge of the mechanisms of molecular-level processes, both normal and malignant.
Molecular Diagnostics is by far the most hastily progressing sector. The oncoming decade will be ear-marked by far-reaching advances in reagent and automation systems, along with the advent of a generous assortment of novelties set to inevitably call for innovative marketing techniques. The percentage of market penetration into day-to-day habitual clinical lab settings, though, will revolve around the arrival of money’s worth and automatized systems with amplification techniques. Some of the firms reigning over the market are Abbott Diagnostics, Celera, Sysmex Corporation, Roche Diagnostics, Qiagen N.V., Siemens Medical Solutions Diagnostics, and more.
The research reports from this Catalogue look at the Molecular Diagnostics Market on every imaginable geography level, covering key technology and medical trends. The issues mentioned in the research reports are varied, ranging from market sizing, share and segmentation to new product introductions and regulatory landscape. Further, the research reports highlight market penetration strategies, potential enter barriers, competitive profiles, besides offering the Molecular Diagnostics Market forecasts.
Publications found:
652
Sort by:
2018 Saudi Arabia Molecular Diagnostic Analyzers and Reagents: Molecular Diagnostic Analyzers and Reagents: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review
US$ 4,250.00
... assays Product/Technology Review Comparison of leading molecular diagnostic analyzers.- Review of molecular diagnostic technologies, test formats, detection methodologies, ... , universities and research centers developing new molecular- diagnostic technologies and products. Competitive Assessments Strategic ...
March 2018
1120 pages
2018 South Korea Molecular Diagnostic Analyzers and Reagents: Molecular Diagnostic Analyzers and Reagents: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review
US$ 4,250.00
... assays Product/Technology Review Comparison of leading molecular diagnostic analyzers.- Review of molecular diagnostic technologies, test formats, detection methodologies, ... , universities and research centers developing new molecular- diagnostic technologies and products. Competitive Assessments Strategic ...
March 2018
1120 pages
2018 United Arab Emirates Molecular Diagnostic Analyzers and Reagents: Molecular Diagnostic Analyzers and Reagents: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review
US$ 4,250.00
... assays Product/Technology Review Comparison of leading molecular diagnostic analyzers.- Review of molecular diagnostic technologies, test formats, detection methodologies, ... Companies, universities and research centers developing new molecular- diagnostic technologies and products. Competitive Assessments ...
March 2018
1120 pages
2018 Czech Republic Molecular Diagnostic Analyzers and Reagents: Molecular Diagnostic Analyzers and Reagents: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review
US$ 4,250.00
... assays. Product/Technology Review Comparison of leading molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends ... , universities and research centers developing new molecular-diagnostic technologies and products. Competitive Assessments Strategic ...
March 2018
1120 pages
2018 Europe Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Market 2021: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 19,700.00
... Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review ... test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...
February 2018
630 pages
